News > Chinese Covid-19 vaccine also found safe, induces immune response

Chinese Covid-19 vaccine also found safe, induces immune response

Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) show that the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years.

The results showed that antibody levels induced by the vaccine were lower than those seen in people who have been infected by and recovered from Covid-19, but researchers said they still expect the vaccine could provide protection from the virus.